Table 2 Thrombotic and ischemic complications depending on anticoagulant treatment
All patients (n = 179) | Prophylactic group (n = 108) | Therapeutic group (n = 71) | Univariable analysis | Multivariable analysis | |||
|---|---|---|---|---|---|---|---|
OR [95% CI] | p | OR [95% CI] | p | ||||
Thrombo-embolic complications—n (%) | 57 (31.8) | 42 (38.9) | 15 (21.1) | 0.42 [0.20–0.88] | 0.01 | 0.38 [0.14–0.94] | 0.04 |
Pulmonary embolisms – n (%) | 25 (14.0) | 22 (20.4) | 3 (4.2) | 0.17 [0.03–0.61] | < 0.01 | 0.19 [0.03–0.81] | 0.04 |
Deep vein thrombosis—n (%) | 11 (6.1) | 10 (9.3) | 1 (1.4) | 0.13 [0–1.39] | 0.18 | 0.13 [0.01–0.89] | 0.04 |
Cerebral ischemic attack—n (%) | 6 (3.4) | 6 (5.6) | 0 | 0 [0–1.27] | 0.09 | 0.06 [0–0.68] | 0.02 |
RRT filter/thrombosis—n (%) | 32 (17.9) | 19 (17.6) | 13 (16.7) | 0.97 [0;41–2.24] | 0.94 | 1.04 [0.34–3.11] | 0.95 |
Nb of RRT filter per day of RRT—median, IQR | 3.0 [1.0; 6.8] | 3.0 [2.0; 7.0] | 2.0 [1.0; 5.0] | / | 0.52 | / | / |